Wells Fargo’s GLOBEIMMUNE INC COM STK (DE) GBIM Stock Holding History

Wells Fargo’s Portfolio GBIM Stock Details GBIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-200	Closed	-$1K	–	6678
2015 Q1	$1K	Sell	200 -200	-50%	-$1.45K	﹤0.01%	6111
2014 Q4	$3K	Hold	400	–	–	﹤0.01%	5984
2014 Q3	$3K	Buy	+400	New	+$4.09K	﹤0.01%	5965

Other funds holding GBIM

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo's GBIM Position: Q2 2015 in Review

Wells Fargo sold out of GLOBEIMMUNE INC COM STK (DE) (GBIM) in Q2 2015, closing a stake of 200 shares — an estimated $1K sold.

Wells Fargo first reported a position in GBIM in Q3 2014 and held it in 3 quarters. The position peaked at $3K in Q4 2014. 9 funds tracked by Wall St. Rank hold GBIM as of Q2 2015.

Wells Fargo reported no remaining GLOBEIMMUNE INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Wells Fargo sold 200 GLOBEIMMUNE INC COM STK (DE) shares in Q2 2015, an estimated $1K.
Wells Fargo first reported a position in GLOBEIMMUNE INC COM STK (DE) in Q3 2014 and held it in 3 quarters.
Wells Fargo's GLOBEIMMUNE INC COM STK (DE) position peaked at $3K in Q4 2014.
9 funds tracked by Wall St. Rank held GLOBEIMMUNE INC COM STK (DE) as of Q2 2015.

Based on Wells Fargo's 13F filing for Q2 2015, filed 14 Aug 2015.